Stock Ratings | HC Wainwright raised its price target for Curis (CRIS) to $43, representing a potential upside of 779.35%; HSBC initiated coverage of SpaceX (SPCX) with a "hold" rating and a price target of $115.
Curis, Inc. CRIS | 0.00 | |
Klaviyo, Inc. Class A KVYO | 0.00 | |
MaxLinear, Inc. MXL | 0.00 | |
Shattuck Labs, Inc. STTK | 0.00 | |
Summit Therapeutics Inc SMMT | 0.00 |
The ratings of major US investment banks are used to track the latest valuations and target prices on Wall Street daily, and to explore potential equity investment opportunities.
Risk warning:
Investing in small-cap stocks can be risky. Be prepared for potential challenges related to liquidity, high volatility, limited information, and financial instability. Always diversify your investments.
Today's key assessments and concerns
HC Wainwright & Co.: Maintaining a "buy" rating on Curis ( Curis, Inc.(CRIS.US) ), while raising the price target from $17 to $43.
Citigroup: Maintaining a "buy" rating on Klaviyo Klaviyo, Inc. Class A(KVYO.US) ) stock, while raising the price target from $31 to $34.
Stifel: Maintaining a "buy" rating on MaxLinear ( MaxLinear, Inc.(MXL.US) ), while raising the price target from $110 to $120.
JP Morgan: Shattuck Labs ( Shattuck Labs, Inc.(STTK.US) ) initial rating at "overweight", with a price target of $10.
Stifel: Maintaining a "buy" rating on Summit Therapeutics Summit Therapeutics Inc(SMMT.US) ) stock, while lowering the price target from $45 to $38.
| The symbol | Classification | Target price | Current price | Percentage of potential increase/decrease | (Classification) Agency |
| Curis, Inc.(CRIS.US) | to lift | $43.0 | $4.89 | 779.35% | HC Wainwright & Co. |
| Klaviyo, Inc. Class A(KVYO.US) | to lift | $34.0 | $16.4 | 107.32% | Citigroup |
| MaxLinear, Inc.(MXL.US) | to lift | $120.0 | $71.59 | 67.62% | Stifel |
| American Airlines Group Inc.(AAL.US) | to lift | $24.0 | $14,475 | 65.8% | JP Morgan |
| CryoPort, Inc.(CYRX.US) | to lift | $25.0 | $15.37 | 62.65% | BTIG |
| Shattuck Labs, Inc.(STTK.US) | Initial classification | $10.0 | $7.43 | 34.59% | JP Morgan |
| Summit Therapeutics Inc(SMMT.US) | cut | $38.0 | $13.66 | 178.18% | Stifel |
| Liberty Energy, Inc. Class A(LBRT.US) | cut | $36.0 | $17.36 | 107.37% | Stifel |
| Alaska Air Group, Inc.(ALK.US) | cut | $92.0 | $46.13 | 99.44% | JP Morgan |
| Liberty Energy, Inc. Class A(LBRT.US) | cut | $34.0 | $17.36 | 95.85% | Piper Sandler |
comments:
Target price unit and current price: US Dollar;
Current price: As of the latest closing price of US stocks;
Potential percentage increase/potential decrease = (Agency target price - current price) / current price 100% (Current price = Last closing price up to the time of the count)
Lifting
Roth Capital: Maintaining a "buy" rating on Advanced Micro Devices, Inc.(AMD.US) stock, while raising the price target from $500 to $650.
Citigroup: Maintaining a "buy" rating on Dell Dell Technologies, Inc. Class C(DELL.US) stock, while raising its price target from $475 to $515.
Truist Securities: Maintaining a "Hold" rating on Hims & Hers Health ( Hims & Hers Health(HIMS.US) ), while raising the price target from $23 to $27.
JP Morgan: Maintaining an "underweight" rating on Intel ( Intel Corporation(INTC.US) ), while raising the price target from $45 to $85.
Truist Securities: Maintaining a "buy" rating on Block ( Block(XYZ.US) ) stock, while raising the price target from $82 to $93.
First Coverage
HSBC: A preliminary rating of "Hold" for SpaceX ( SpaceX(SPCX.US) ) stock, with a price target of $115.
JP Morgan: Shattuck Labs ( Shattuck Labs, Inc.(STTK.US) ) initial rating at "overweight", with a price target of $10.
Mizuho: Initial rating for SunocoCorp ( SunocoCorp LLC(SUNC.US) ) at "outperforms the market", with a price target of $83.
reduction
Citigroup: Maintaining a "buy" rating on IBM IBM Corp(IBM.US) ) stock, while lowering the price target from $255 to $245.
Stifel: Maintaining a "Hold" rating on Intel ( Intel Corporation(INTC.US) ) stock, while lowering the price target from $120 to $110.
Barclays: Maintaining an "overweight" rating on T-Mobile US T-Mobile US, Inc.(TMUS.US) ) stock, while lowering its price target from $230 to $215.
Editor's Note: This content was created by Saham's AI-powered SaaS tool and reviewed by our editorial team.
Risk Warning: Investing involves risk. Securities may rise, fall, or become worthless. Investing does not guarantee profits and may result in losses. Past performance is not necessarily indicative of future results. Before making any investment decision, investors should assess their financial situation, investment objectives, experience, risk tolerance, and understand the nature of the investment products and their associated risks. For more details on the nature and risks of each investment product, please read the relevant offering documents carefully. If you have any questions, it is advisable to seek independent professional advice.